PerkinElmer
check quantity

HCA ImagAmp 546 Reagent Kit, 5 microplates

HCA ImagAmp kits for amplified detection of fluorescent signal in high content screening (HCS) applications.

Based on 30 µL per well of Fluorophore Amplification Reagent Working Solution

Part Number
Unit Size
List Price
Your Price
Quantity
NEL774001KT
1 microplate
492.00 USD
 
more
NEL774B001KT
5 microplates
2155.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

HCA ImagAmp 546 kits provide signal amplification for high content screening and analysis assays, delivering enhanced sensitivity and improved dynamic range. It is ideal for assays with very low signal due to low abundance of the analyte or weakly associated primary antibodies. The HCA ImagAmp protocol results in covalent deposition of multiple fluorophores proximal to the analyte during a simple 10-minute incubation step.

Specifications

Detection Method Fluorescence
Product Brand Name HCA ImagAmp
Quantity in a Package Amount 5.0 Units
Shipping Condition Blue Ice
Unit Size 5 microplates
Resources, Events & More
  • All

Brochure

Drug Discovery Screening Solutions Brochure

Find out about our range of integrated solutions for drug discovery screening in this e-brochure.

Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automated liquid handling, assays and reagents, imaging and detection systems, and informatics.

Working independently or together, with our solutions you can achieve consistent and accurate results. By accelerating the identification and characterization of effective and safe drug candidates, the PerkinElmer portfolio enables you to optimize efficiency in your lab and deliver more actionable, real-world results.

Download the brochure to learn more about how we can partner with you so that you can discover smarter, more effective, data-driven breakthroughs in the critical screening stages of drug discovery and development.

PDF 4 MB